Programmed T cell differentiation is critically influenced by the complement of costimulatory and coinhibitory signals transmitted during initial antigen encounter. We previously showed that selective CD28 blockade with novel domain antibodies that leave CTLA-4-mediated coinhibitory signaling intact resulted in more profound attenuation of donor-reactive T cell responses and improved graft survival in a murine transplant model. Selective CD28 block-ade was also associated with decreased ICOS expression on donor-reactive CD8+ T cell responses as compared to CTLA-4 Ig, but the functional importance of this reduced ICOS expression was not known. In this study, we created retrogenic donor-reactive CD8+ T cells that overexpress ICOS in order to ...
International audienceT cells are central to the detrimental alloresponses that develop in autoimmun...
<p>10<sup>6</sup> CD45.2<sup>+</sup> Thy1.2<sup>+</sup> OT-I (black) or 10<sup>6</sup> CD45.2<sup>+<...
Emory University will soon commence a Phase 2 clinical trial testing the efficacy of Lulizumab, a dr...
Programmed T cell differentiation is critically influenced by the complement of costimulatory and co...
<p>Naïve B6 animals were adoptively transferred with 10<sup>6</sup> congenically labeled ICOSrg Thy1...
<p>Naïve B6 animals were adoptively transferred with 10<sup>6</sup> congenically labeled ICOSrg Thy1...
Contains fulltext : 49869.pdf (publisher's version ) (Closed access)Blockade of co...
International audienceCD28 and CTLA-4 are prototypal co-stimulatory and co-inhibitory cell surface s...
International audienceCD28 and CTLA-4 are prototypal co-stimulatory and co-inhibitory cell surface s...
International audienceCD28 and CTLA-4 are prototypal co-stimulatory and co-inhibitory cell surface s...
International audienceCD28 and CTLA-4 are prototypal co-stimulatory and co-inhibitory cell surface s...
International audienceT cells are central to the detrimental alloresponses that develop in autoimmun...
T cells are central to the detrimental alloresponses that develop in autoimmunity and transplantatio...
<p>Naïve B6 animals were adoptively transferred with 10<sup>6</sup> congenically labeled ICOSrg Thy1...
International audienceT cells are central to the detrimental alloresponses that develop in autoimmun...
International audienceT cells are central to the detrimental alloresponses that develop in autoimmun...
<p>10<sup>6</sup> CD45.2<sup>+</sup> Thy1.2<sup>+</sup> OT-I (black) or 10<sup>6</sup> CD45.2<sup>+<...
Emory University will soon commence a Phase 2 clinical trial testing the efficacy of Lulizumab, a dr...
Programmed T cell differentiation is critically influenced by the complement of costimulatory and co...
<p>Naïve B6 animals were adoptively transferred with 10<sup>6</sup> congenically labeled ICOSrg Thy1...
<p>Naïve B6 animals were adoptively transferred with 10<sup>6</sup> congenically labeled ICOSrg Thy1...
Contains fulltext : 49869.pdf (publisher's version ) (Closed access)Blockade of co...
International audienceCD28 and CTLA-4 are prototypal co-stimulatory and co-inhibitory cell surface s...
International audienceCD28 and CTLA-4 are prototypal co-stimulatory and co-inhibitory cell surface s...
International audienceCD28 and CTLA-4 are prototypal co-stimulatory and co-inhibitory cell surface s...
International audienceCD28 and CTLA-4 are prototypal co-stimulatory and co-inhibitory cell surface s...
International audienceT cells are central to the detrimental alloresponses that develop in autoimmun...
T cells are central to the detrimental alloresponses that develop in autoimmunity and transplantatio...
<p>Naïve B6 animals were adoptively transferred with 10<sup>6</sup> congenically labeled ICOSrg Thy1...
International audienceT cells are central to the detrimental alloresponses that develop in autoimmun...
International audienceT cells are central to the detrimental alloresponses that develop in autoimmun...
<p>10<sup>6</sup> CD45.2<sup>+</sup> Thy1.2<sup>+</sup> OT-I (black) or 10<sup>6</sup> CD45.2<sup>+<...
Emory University will soon commence a Phase 2 clinical trial testing the efficacy of Lulizumab, a dr...